In a possible development, an Israeli Defense Ministry-run laboratory claimed it had finished effective coronavirus vaccine trials on rodents, leading the way to further screening on other animals and after that potentially human trials.
In a paper released Friday on the site of bioRxiv, an online repository for documents that have not yet been peer-reviewed, the Israel Institute for Biological Research Study, which is based in Ness Ziona, stated it hopes to have a completed vaccine in a year, or potentially even earlier.
In the abstract of the report, the researchers state their vaccine, which they checked on hamsters, “results in rapid and powerful induction of reducing the effects of antibodies against SARS-CoV-2,” the virus that causes COVID-19
Get The Times of Israel’s Daily Edition by e-mail and never miss our top stories.
Free Sign Up.
Throughout the trials, 2 groups of rodents were contaminated with the coronavirus, however just one group had actually first been provided the vaccine. Whereas the unvaccinated group ended up being ill, the immunized rodents stayed healthy, researchers claimed.
” Importantly, single-dose vaccination was able to safeguard hamsters against SARS-CoV-2 challenge, as demonstrated by the abrogation of body weight reduction of the immunized hamsters compared to unvaccinated hamsters,” they wrote in the report.
While the lungs of contaminated hamsters showed comprehensive tissue damage and a high viral load, the report said th